Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB4211
    • CB5138 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 07, 2019 4:03pm EDT

CohBar Reports First Quarter 2019 Financial Results and Business Update

May 07, 2019 9:00am EDT

CohBar Appoints Steven B. Engle as Chief Executive Officer

May 03, 2019 9:00am EDT

CohBar to Resume its Phase 1a/1b Clinical Trial

Apr 26, 2019 3:35pm EDT

CohBar to Announce 2019 First Quarter Financial Results and Provide Business Update on May 7, 2019

Apr 23, 2019 9:00am EDT

CohBar Announces Key Opinion Leader Conference Call and Webcast

Apr 22, 2019 9:00am EDT

CohBar Announces the Appointment of David Greenwood to its Board of Directors

Mar 18, 2019 4:03pm EDT

CohBar Reports Fourth Quarter 2018 Financial Results and Provides Business Update

Mar 04, 2019 9:00am EST

CohBar to Announce 2018 Fourth Quarter Financial Results and Host Conference Call on March 18, 2019

Feb 11, 2019 9:00am EST

CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors

Dec 10, 2018 4:05pm EST

CohBar Appoints Philippe P. Calais, Pharm.D., Ph.D. as Interim Chief Executive Officer

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Page 18
  • Next Pagearrow_forward
  • Email Alerts
  • Tear Sheet
  • Contacts
©2023 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use